CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma (VIDEO)

Dana-Farber Cancer Institute

Caption

A lymphoma patient shares her story about how she benefitted from a CAR-T clinical trial. Dr. Caron Jacobson is presenting the results from ZUMA-5 at this year's ASH conference.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

Courtesy of Dana-Farber Cancer Institute

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.